German Pharmaceuticals & Biotech Potentially Undervalued Companies

Tecan Group

Market Cap: €2.0b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Revolution Medicines

Market Cap: €8.4b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Theratechnologies

Market Cap: €208.3m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

aTyr Pharma

Market Cap: €105.8m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

GSK

Market Cap: €59.3b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Beximco Pharmaceuticals

Market Cap: €54.5b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

PharmaSGP Holding

Market Cap: €340.8m

Manufactures and sells over-the-counter drugs and other healthcare products in Germany.

Sangamo Therapeutics

Market Cap: €154.7m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Towa Pharmaceutical

Market Cap: €143.7b

Manufactures and sale ethical drugs in Japan.

IQVIA Holdings

Market Cap: €31.7b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Pharming Group

Market Cap: €831.8m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Biofrontera

Market Cap: €8.1m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Xenetic Biosciences

Market Cap: €6.4m

A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.

MEI Pharma

Market Cap: €49.6m

A clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.

BioNTech

Market Cap: €24.6b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

UCB

Market Cap: €38.6b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Mirum Pharmaceuticals

Market Cap: €3.7b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Johnson & Johnson

Market Cap: €425.0b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Asymchem Laboratories (Tianjin)

Market Cap: €41.4b

Asymchem Laboratories (Tianjin) Co., Ltd.

Supernus Pharmaceuticals

Market Cap: €2.5b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Axsome Therapeutics

Market Cap: €5.7b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Protara Therapeutics

Market Cap: €118.4m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Genovis AB (publ.)

Market Cap: €1.6b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Eisai

Market Cap: €1.4t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Arctic Bioscience

Market Cap: €106.1m

A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.

Roche Holding

Market Cap: €223.6b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Autolus Therapeutics

Market Cap: €351.3m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Veracyte

Market Cap: €2.5b

Operates as a diagnostics company in the United States and internationally.

Bio-Techne

Market Cap: €8.1b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Alterity Therapeutics

Market Cap: €119.6m

Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.

ALK-Abelló

Market Cap: €46.1b

Operates as an allergy solutions company in Europe, North America, and internationally.

argenx

Market Cap: €38.4b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Daiichi Sankyo Company

Market Cap: €6.5t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

UCB

Market Cap: €38.6b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

ImmuCell

Market Cap: €51.1m

An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.

Swedencare

Market Cap: €6.3b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.